Cartesian Therapeutics
RNAC
#6795
Rank
A$0.72 B
Marketcap
$28.39
Share price
11.01%
Change (1 day)
-46.48%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.69 Billion

According to Cartesian Therapeutics's latest financial reports the company's total liabilities are A$0.69 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cartesian Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$1.09 B933.01%
2022-12-31A$0.10 B-44.11%
2021-12-31A$0.18 B-20.58%
2020-12-31A$0.23 B83.2%
2019-12-31A$0.13 B83.84%
2018-12-31A$70.83 M12.2%
2017-12-31A$63.13 M32.5%
2016-12-31A$47.64 M-78.21%
2015-12-31A$0.21 B62.73%
2014-12-31A$0.13 B